|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Spleen-preserving distal pancreatectomy with conservation of the splenic artery and vein显示文摘Preservation of the spleen at distal pancreatectomy has recently attracted considerable attention.Since our first successful trial,spleen-preserving distal pancreatectomy with conservation of the splenic artery and vein for tumors of the pancreas and chronic pancreatitis has been performed more frequently.The technique for spleen-preserving distal pancreatectomy with conservation of the splenic artery and vein are outlined.The splenic vein is identified behind the pancreas and within the thin connective tissue membrane.The connective tissue membrane is cut longitudinally above the splenic vein.An important issue is to remove the splenic vein from the body of the pancreas toward the spleen,since a different approach may be very difficult.The pancreas is preferably removed from the splenic artery toward the head of the pancreas itself.This procedure is much easier than removing the pancreas from the vein side.One patient had undergone distal gastrectomy for duodenal ulcer,with reconstruction by Billroth Ⅱ tehcnique.If distal pancreatectomy with splenectomy had been performed for the lesion of the distal pancreas at the time,the residual stomach would also have to be resected.The potential damage done to the patient by reconstruction of the gastrointestinal tract in combination with distal pancreatectomy and splenectomy would have been much greater than with distal pancreatectomy only with preservation of the spleen and residual stomach.Benign lesions as well as low-grade malignancy of the body and tail of the pancreas may be a possible indication for this procedure. | Wataru Kimura Toshiyuki Moriya Jinfeng Ma Yukinori Kamio Toshihiro Watanabe Mitsukiro Yano Hiroto Fujimoto Koji Tezuka Ichiro Hirai Akira Fuse | 2007 | World Journal of Gastroenterology2007，13，10： | 24 |
| 2 | Synthesis, characterization and therapeutic efficacy of a biodegradable, thermoresponsive hydrogel designed for application in chronic infarcted myocardium显示文摘 | Fujimoto K L Ma Z W Nelson D M | 2009 | Biomaterials2009，30，26： | 1 |
| 3 | Insulin and amylin release are both diminished in first degree relatives of subjectswith type 2 diabetes显示文摘 | Knowles NG Fujimoto WY Landchild MA | 2002 | Diabetes Care2002，25，： | 1 |
| 4 | Pharmacologic retinoid signaling and physiologic retinoic acid receptor signaling inhibit basal cell carcinoma tumorigenesis 显示文摘 | So PL Fujimoto MA Epstein EH Jr | 2008 | Mol Cancer Ther2008，7，5： | 1 |
| 5 | Insulin and amylin release are both diminished in first-degree relatives of subjects with type 2 diabetes显示文摘 | Knowles NG Fujimoto WY Landchild MA | 2002 | Diabetes Care2002，25，2： | 1 |
| 6 | Synthesis,characterization and therapeutic efficacy of a biodegradable,thermoresponsive hydrogel designed for application in chronicinfarcted myocardium显示文摘 | Fujimoto K L Ma Z W Nelson D M | 2009 | Biomaterials2009，30，26： | 1 |
| 7 | In non-obese pa- tients,duration of action of rocuronium is directly corre- lated with body mass index显示文摘 | Fujimoto M Tanahira C Nishi MA | 2013 | Can J Anaesth2013，60，6： | 1 |
| 8 | Novel Role of gp91phox-Containing NAD(P)H Oxidase in Vascular Endothelial Growth Factor–Induced Signaling and Angiogenesis显示文摘 | Masuko Ushio-Fukai Yan Tang Tohru Fukai Sergey I. Dikalov Yuxian Ma Mitsuaki Fujimoto Mark T. Quinn Patrick J. Pagano Chad Johnson R. Wayne Alexander | 2002 | Circulation Research: Journal of the American Heart Association2002，，12： | 1 |
| 9 | Bacillus Calmette- Guerin plus interleukin - 2 and/or granulocyte/macrophage- colony- stimulating factor enhances immunocompetent cell production of interferon - gamma, which inhibits B16F10 melanoma cell growth in vitro显示文摘 | Fujimoto T O' Donnell MA Szilvasi A | 1996 | Cancer Immunol Immunother1996，42，5： | 1 |
| 10 | Single-cell transcriptomic analysis uncovers intratumoral heterogeneity and drug-tolerant persister in ALK-rearranged lung adenocarcinoma显示文摘Dear Editor,Non-small cell lung carcinoma(NSCLC)accounts for more than 85%of all lung cancers[1].Lung adenocarcinomas(ADCs)arising from never-smokers have been frequently found to be associated with oncogenic driver mutations,including anaplastic lymphoma kinase(ALK)rearrangement.Echinoderm microtubule-associated protein-like 4(EML4)is the most common fusion partner of the ALK gene[2].Tyrosine kinase inhibitors(TKIs)are currently the first-line treatment for advanced EML4-ALKrearranged lung ADC. | Hoi-Hin Kwok Huiyu Li Jiashuang Yang Junyang Deng Nerissa Chui-Mei Lee Timmy Wing-Kuk Au Alva Ko-Yung Sit Michael Kuan-Yew Hsin Stephanie Kwai-Yee Ma LydiaWai-Ting Cheung Luc Girard Junya Fujimoto Ignacio Ivan Wistuba Boning Gao John Dorrance Minna David Chi-Leung Lam | 2023 | Cancer Communications2023，43，8： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员